Skip to main content
Premium Trial:

Request an Annual Quote

Abcam To Use Transinsight Search Technology for Antibody Informatics Platform

NEW YORK (GenomeWeb News) – Antibody supply company Abcam said today that it will collaborate with semantic search technology firm Transinsight on a bioinformatics workflow platform designed to help Abcam’s customers search for products.
 
Abcam, headquartered in Cambridge, UK, with offices in Cambridge, Mass and Tokyo, supplies research-grade antibodies to academic and commercial customers through an online catalogue.
 
Dresden, Germany-based Transinsight develops knowledge-based biomedical search engines.
 
"Until recently there were only limited software tools and scientific workflows available to help us automatically produce high quality data sets surrounding each of Abcam’s thousands of antibody targets,” Abcam’s Senior Business Development Manager, Juergen Harter, said in a statement.
 
“We need these data sets to help our customers find the right products", Harter added.
 
The company said that it was looking to develop an “automated intelligent computer-based solution” to deliver information about proteins.
 
Financial terms of the agreement were not released.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.